ARCHIVES

Biomarker Test Outperforms PSA and Gleason Score in Study

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Number of Clinical R01 Applications Doubles; Funding Rate Below 20%; NCI Execs Not Satisfied

July 17, 1992

Leptin Could Be Indicator Of Breast Cancer Risk

April 25, 2003

DCT Board Okays Consideration Of New New Heavy Particle Therapy Studies

March 8, 1985

Eight Centers Picked To Host Regional Breast Cancer Summits

January 31, 1992

Underpowered Study Of Evacet Dashes Approval Hopes

September 24, 1999

FDA Approves Genetic Test For Breast Cancer Patients

January 25, 2008